Latest News and Press Releases

Austin, TX, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Ultrasonic Dissection Devices Market Size, Trends and Insights By Product...

New York, United States , May 29, 2023 (GLOBE NEWSWIRE) -- The Global Laparoscopic Devices Market Size is to grow from USD 7.2 billion in 2022 to USD 16.3 billion by 2032, at a Compound Annual...

SAN JOSE, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Suture Ease, a leading developer of medical devices that close fascial defects after laparoscopic surgery, will exhibit at the annual Society of...

WASHINGTON, March 01, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Reprocessed Medical Devices Market finds that increasing the adoption of Reprocessed Medical...

FRAMINGHAM, MA--(Marketwired - Jul 25, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...

FRAMINGHAM, MA--(Marketwired - Jun 6, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...

FRAMINGHAM, MA--(Marketwired - May 22, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be...

FRAMINGHAM, MA--(Marketwired - Mar 6, 2017) - Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and...

FRAMINGHAM, MA--(Marketwired - Feb 27, 2017) -  Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic...

FRAMINGHAM, MA--(Marketwired - Feb 21, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a developer of innovative materials as hemostatic and wound care devices, today...